(S)-2-amino-3-(naphthalen-2-yl)-N-(2-oxo-2-(1,2,3,4-tetrahydroacridin-9-ylamino)ethyl)propanamide
(S)-2-amino-3-(naphthalen-2-yl)-N-(2-oxo-2-(1,2,3,4-tetrahydroacridin-9-ylamino)ethyl)propanamide
| SMILES |
C1CCC2=NC3=CC=CC=C3C(=C2C1)NC(=O)CNC(=O)C(CC4=CC5=CC=CC=C5C=C4)N |
| InChIKey |
XUPAFAYCDTZDFV-UHFFFAOYSA-N |
Chemical Properties
| Hydrogen bond acceptors |
4 |
| Hydrogen bond donors |
3 |
| Rotatable bonds |
6 |
| Molecular weight (Da) |
452.2 |
Bioactivities
|
| Receptor |
Activity |
Source |
| Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
|
| Receptor |
Activity |
Source |
| Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
(S)-2-amino-3-(naphthalen-2-yl)-N-(2-oxo-2-(1,2,3,4-tetrahydroacridin-9-ylamino)ethyl)propanamide
Drug properties
| Molecular type |
Small molecule |
| Physiological/Surrogate |
Surrogate |
| Approved drug |
No |
Clinical Trials
Phase I
0
Phase II
0
Phase III
0
Approved
No
Sankey plot
Compound is not listed as a drug.